A mouse study at WashU Medicine shows how Alzheimer’s disease reprograms genes in specialized cells involved in amyloid plaque removal.| WashU Medicine
NIH funding aims to accelerate drug development timeline for enhanced version of naloxone| WashU Medicine
Could help determine which patients are likely to benefit from new Alzheimer’s drugs| WashU Medicine
Leaders in medical education, research and patient care, WashU Medicine is among the top medical schools in the nation.| WashU Medicine
Analyzing rates by age, race, tumor characteristics could inform prevention strategies| WashU Medicine